NCT01541735
Pantoprazole on Insulin Secretion in Diabetes
See it on ClinicalTrials.gov ↗14 people
78.6%
21.4%
11 womenmiddle line = equal numbers3 men
- Phase
- PHASE2, PHASE3
- Paid for by
- Coordinación de Investigación en Salud, Mexico
- Finished
- 2013-05
- Health conditions
- Type 2 Diabetes
- Who could join
- Anyone
- Ages
- 30 Years – 60 Years
- Average age
- mean 48.0 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 60 Years.”
- No pregnant women
Women who were pregnant could not join.
“Women pregnant or stage of lactation”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Women pregnant or stage of lactation”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index 30.0 to 39.9 and body weight stable for at least 3 months before the study”
- No diabetes
Women with diabetes were turned away.
“Diabetes complications”
Study titles and rules are shown in their original English.